Current devices and complications related to transcatheter mitral valve replacement: the bumpy road to the top

F Kargoli, M Pagnesi, K Rahgozar… - Frontiers in …, 2021 - frontiersin.org
Mitral regurgitation is the most common valvular lesion in the developed world, with
increasing prevalence, morbidity, and mortality. The experience with surgical mitral valve …

[HTML][HTML] Role of imaging in novel mitral technologies—echocardiography and computed tomography

C Loghin, A Loghin - Annals of Cardiothoracic Surgery, 2018 - ncbi.nlm.nih.gov
As minimally invasive cardiovascular procedures gain popularity, novel transcatheter mitral
valve repair devices continue to emerge. The success of these technologies is critically …

[HTML][HTML] Percutaneous transapical closure of paravalvular leak in bioprosthetic mitral valve without radio-opaque indicators

M Celik, UC Yuksel - Cardiovascular Diagnosis and Therapy, 2019 - ncbi.nlm.nih.gov
Percutaneous transapical closure of paravalvular leak in bioprosthetic mitral valve without
radio-opaque indicators - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

Percutaneous therapies for mitral valve disease

A Parashar, EM Tuzcu, SR Kapadia - Cardiovascular …, 2017 - taylorfrancis.com
The prevalence of mitral valve disease, especially mitral regurgitation (MR), is increasing.
Despite significant gains in the eradication of rheumatic fever, rheumatic mitral stenosis (MS) …

[引用][C] 超声评估冠状动脉粥样硬化性心脏病患者二尖瓣环移位参数及其与血清Hcy, vWF 及CysC 水平的相关性研究

樊蓉, 任卫东 - 中国现代医学杂志, 2020